Vitamin D status: Ready for guiding prostate cancer diagnosis and treatment?

Clinical Cancer Research

Volumn 20, Issue 9, 2014, Pages 2241-2243

  Grant, William B ^a  

^a Sunlight Nutrition and Health Research Center ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; CALCIUM; COLECALCIFEROL; PROSTATE SPECIFIC ANTIGEN; 25-HYDROXYVITAMIN D; VITAMIN D;

25 HYDROXYCOLECALCIFEROL BLOOD LEVEL; ARTICLE; BLOODSTREAM INFECTION; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RISK; CANCER STAGING; DIGITAL RECTAL EXAMINATION; DISEASE ACTIVITY; DISEASE ASSOCIATION; GLEASON SCORE; HISTOPATHOLOGY; HUMAN; LIFE EXPECTANCY; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; NUTRITIONAL STATUS; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE SURGERY; RISK ASSESSMENT; SURVIVAL RATE; SURVIVAL TIME; TUMOR INVASION; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION; ANALOGS AND DERIVATIVES; BLOOD; MALE; PATHOLOGY; PROSTATE; PROSTATIC NEOPLASMS;

HUMANS; MALE; PROSTATE; PROSTATIC NEOPLASMS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84899706421     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-14-0369     Document Type: Article

References (13)

1. Murphy AB, Nyame Y, Martin IK, Catalona WJ, Hollowell CMP, Nadler RB, et al. VitaminDdeficiency predicts prostate biopsy outcomes. Clin Cancer Res 2014;20:2289-99.
2. Gilbert R, Metcalfe C, Fraser WD, Donovan J, Hamdy F, Neal DE, et al. Associations of circulating 25-hydroxyvitamin D with prostate cancer diagnosis, stage and grade. Int J Cancer 2012;131:1187-96.
3. Hoffman RM, Penson DF, Zietman AL, Barry MJ. Comparative effectiveness research in localized prostate cancer treatment. J Comp Eff Res 2013;2:583-93.
4. Loeb S, Vellekoop A, Ahmed HU, Catto J, Emberton M, Nam R, et al. Systematic review of complications of prostate biopsy. Eur Urol 2013;64:876-92.
5. Active surveillance for early-stage prostate cancer. Lancet 2014; 383:188.
6. van den Bergh RC, Ahmed HU, Bangma CH, Cooperberg MR, Villers A, Parker CC. Novel tools to improve patient selection and monitoring on active surveillance for low-risk prostate cancer: a systematic review. Eur Urol 2014 Jan 28 [Epub ahead of print].
7. Grant WB, Peiris AN. Differences in vitamin D status may account for unexplained disparities in cancer survival rates between African and White Americans. Dermatoendocrinol 2012;4:85-94.
8. Hollis BW, Marshall DT, Savage SJ, Garrett-Mayer E, Kindy MS, Gattoni-Celli S. Vitamin D(3) supplementation, low-risk prostate cancer, and health disparities. J Steroid Biochem Mol Biol 2013;136: 233-7.
9. Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 2011;96:53-8.
10. Der T, Bailey BA, Youssef D, Manning T, Grant WB, Peiris AN. Vitamin D and prostate cancer survival in veterans. Mil Med 2014; 179:81-4.
11. Krishnan AV, Feldman D. Vitamin D and prostate cancer. Ch. 86 in Vitamin D. 3rd ed. In: Feldman D, PikeJW, Adams JS, editors. Academic Press; 2011. p. 1675-709.
12. Heaney RP. Guidelines for optimizing design and analysis of clinical studies of nutrient effects. Nutr Rev 2014;72: 48-54.
13. Hossein-Nezhad A, Holick MF. Vitamin D for health: a global perspective. Mayo Clin Proc 2013;88:720-55.